ATLANTA, Nov. 3, 2014 /PRNewswire/ -- Elekta's (EKTA-B.ST)
Clarity® 4D prostate monitoring system can now
automatically interrupt, or "gate," the radiation beam when it
detects that the prostate has moved out of position. Clarity 4D
Monitoring software has enabled doctors to continuously visualize
the prostate's precise location during radiation therapy. FDA
510(k) clearance for Clarity to be used with Elekta's Response
gating interface will give US physicians the potential to further
safeguard the patient's normal tissues from overexposure to
radiation during prostate radiotherapy. The feature is available as
an option with Elekta's advanced Versa HD™ radiation therapy
treatment system.
Reliably localizing the prostate is critical during precision
radiotherapy, as dose is being constantly delivered to its assumed
location even though the prostate's position may be changing due to
pressure from surrounding anatomy such as the bladder or
rectum.
"The Clarity system permits clinicians to set the amount of
prostate movement allowable over a given period, for example, three
or five millimeters for a five-second period, depending on the dose
rate and other factors," explains Tony
Falco, Senior Vice President, Elekta
Software. "When Clarity detects anything over this limit,
the treatment is automatically paused to allow clinicians to
correct for the motion. This could be especially important for
clinicians pursuing advanced prostate protocols, such as reduced
margin hypofractionated therapy or stereotactic body radiation
therapy [SBRT]."
Automated beam gating with Response will also help streamline
prostate radiotherapy workflow by removing the human reaction time
to prostate position alerts, he adds.
For further information, please contact:
Gert van Santen, Group Vice President Corporate
Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Kris Walmsley, Corporate
Communications Manager, Elekta
AB
Tel: +46 70 537 9545, e-mail: kris.walmsley@elekta.com
Time zone: CET: Central European Time
About Elekta
Elekta is a human care company pioneering
significant innovations and clinical solutions for treating cancer
and brain disorders. The company develops sophisticated,
state-of-the-art tools and treatment planning systems for radiation
therapy, radiosurgery and brachytherapy, as well as workflow
enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence
to both health care providers and patients, Elekta aims to improve,
prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in
over 6,000 hospitals worldwide. Elekta employs around 3,800
employees globally. The corporate headquarters is located in
Stockholm, Sweden, and the company
is listed on NASDAQ Stockholm. Website: www.elekta.com.
SOURCE Elekta
